RCRS currently participates in 21 studies in Phases I through IV for clients based in countries like the USA, the UK, the Middle East and India. RCRS is committed to providing professional, confidential, innovative and effective clinical trial solutions in cooperation with hospital investigators and regulatory authorities. As part of its efforts to achieve prominence in the field of global clinical research, RCRS has set up a state-of-the-art Phase I unit and is scaling up to undertake global trials as India\'s first e-CRO.
Reliance Clinical Research Services (RCRS), a full-service contract clinical research organisation, is a business initiative of the $23bn Reliance Group, which meets the contract clinical research service needs of pharmaceutical, biotechnology and medical device companies at a global level. Its range of services include project management, protocol design, clinical trial supplies management, clinical operations, molecular diagnostic central lab services, biometrics, training, translations, regulatory affairs, quality assurance, pharmacovigilance and medical writing. These are carried out with a focus on quality, speed and cost-effectiveness.
RCRS has developed a broad network through relationships with investigators and opinion leaders, as well as alliances with global contract research organisations (CROs). RCRS leverages the advantages India offers in the area of contract clinical research, such as the availability of well-trained investigators, technical professionals certified in ICH-GCP guidelines, large patient populations with varied disease profiles and genetic diversity, the therapy na•ve market, the large number of tertiary hospitals and certified central laboratories. The growing reputation of RCRS in international markets is based on its strong track record and responsiveness to client needs.
RCRS currently participates in 21 studies in Phases I through IV for clients based in countries like the USA, the UK, the Middle East and India. RCRS is committed to providing professional, confidential, innovative and effective clinical trial solutions in cooperation with hospital investigators and regulatory authorities. As part of its efforts to achieve prominence in the field of global clinical research, RCRS has set up a state-of-the-art Phase I unit and is scaling up to undertake global trials as India's first e-CRO.
Further information
Reliance Life Sciences Pvt Ltd
Email: rcrs@relclin.com
Website: www.relclin.com
